- Publication
- Mar 13, 2018
In silico Predicted Glucose-1-phosphate Uridylyltransferase (GalU) Inhibitors Block a Key Pathway Required for Listeria Virulence
Kuenemann, et al. Mol. Inf., 2018, 37, 1800004- Publication
- Mar 13, 2018
Cheminformatics Analysis of Dynamic WNK-InhibitorInteractions
Kuenemann, et al. Mol. Inf., 2018, Article ASAP, DOI: 10.1002/minf.201700138- Publication
- Aug 28, 2017
Investigating Protein-Peptide Interactions Using the Schr’dinger Computational Suite
Bhachoo, et al. Methods Mol Biol., 2017, 1561, 235-254- Publication
- May 16, 2017
Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action
Ban, et al. J. Chem. Inf. Model., 2017, 57(5), 1018-1028- Publication
- May 16, 2017
Characterizing the Chemical Space of ERK2 Kinase Inhibitors Using Descriptors Computed from Molecular Dynamics Trajectories
Ash, et al. J. Chem. Inf. Model., 2017, 57 (6), 1286-1299- Publication
- Mar 29, 2017
Adverse Drug Reactions Triggered by’the Common HLA-B*57:01 Variant: A Molecular Docking Study
Van Den Driessche, et al. J. Cheminform., 2017, 9 (13), 1-17- Publication
- Mar 15, 2017
Prospective Evaluation of Free Energy Calculations for the Prioritization of Cathepsin L Inhibitors
Kuhn, et al. J. Med. Chem., 2017, 60 (6), 2485-2497- Publication
- Nov 28, 2016
Relative Binding Free Energy Calculations Applied to Protein Homology Models
Cappel, et al. J. Chem. Inf. Model., 2016, 56 (12), 2388-2400- Publication
- Aug 26, 2016
Discovery and Structure Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening
Dighe, et al. J. Med. Chem., 2016, 59, 7683-7689- Publication
- Sep 8, 2015
Development and Characterization of Nonpeptidic Small Molecule Inhibitors of the XIAP/Caspase-3 Interaction
Wu, et al. Chemistry & Biology, 2003, 10, 759-767- Publication
- Sep 8, 2015
Molecular Docking of Carbohydrate Ligands to Antibodies: Structural Validation against Crystal Structures
Agostino, et al. J. Chem. Inf. Model., 2009, 49, 2749-2760- Publication
- Sep 8, 2015
Long-range electrostatic complementarity governs substrate recognition by human chymotrypsin C, a key regulator of digestive enzyme activation
Batra, et al. J. Biol. Chem., 2013, 288(14), 9848-9859
Latest insights from Extrapolations blog
With FEP+, “The Experiment is the Limit.”
Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods
The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.
Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In
We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.
Training & Resources
Online certification courses
Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.
Free learning resources
Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.
Other Resources